title: Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.
abstract: Children with sickle cell anemia (HbSS) are at high risk for neurologically overt cerebral infarcts associated with stroke and neurologically silent cerebral infarcts correlated with neuropsychometric deficit. We used complete magnetic resonance imaging (MRI) histories from 266 HbSS children, aged 6 through 19 years, who were enrolled in the Cooperative Study of Sickle Cell Disease (CSSCD) to examine silent infarct prevalence, localization, recurrence, and progression. We report a baseline prevalence of 21.8%, marginally higher than previously reported due to improved imaging technologies. Although we observed no overall sex difference in prevalence, most lesions in girls occurred before age 6, whereas boys remained at risk until age 10. Silent infarcts were significantly smaller and less likely to be found in the frontal or parietal cortex than were infarcts associated with stroke. Children with silent infarct had an increased incidence of new stroke (1.03/100 patient-years) and new or more extensive silent infarct (7.06/100 patient-years) relative to stroke incidence among all children in our cohort (0.54/100 patient-years). Both events were substantially less frequent than the risk of stroke recurrence among children not provided chronic transfusion therapy. Although chronic transfusion is known to decrease occurrence of new silent infarcts and strokes in children with elevated cerebral arterial blood flow velocity, further study is required to determine its risk-benefit ratio in children with silent infarct and normal velocities. Until safe and effective preventive strategies against infarct recurrence are discovered, MRI studies are best reserved for children with neurologic symptoms, neuropsychometric deficits, or elevated cerebral artery velocities.
authors.affiliation: Department of Pediatrics, University of Miami, Miami, FL 33101, USA. cpegelow@miami.edu
authors.forename: Charles H
authors.initials: CH
authors.lastname: Pegelow
authors.forename: Eric A
authors.initials: EA
authors.lastname: Macklin
authors.forename: Franklin G
authors.initials: FG
authors.lastname: Moser
authors.forename: Winfred C
authors.initials: WC
authors.lastname: Wang
authors.forename: Jacqueline A
authors.initials: JA
authors.lastname: Bello
authors.forename: Scott T
authors.initials: ST
authors.lastname: Miller
authors.forename: Elliott P
authors.initials: EP
authors.lastname: Vichinsky
authors.forename: Michael R
authors.initials: MR
authors.lastname: DeBaun
authors.forename: Ludovico
authors.initials: L
authors.lastname: Guarini
authors.forename: Robert A
authors.initials: RA
authors.lastname: Zimmerman
authors.forename: Donald P
authors.initials: DP
authors.lastname: Younkin
authors.forename: Dianne M
authors.initials: DM
authors.lastname: Gallagher
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Kinney
mesh_terms: D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000473:pathology / Q000628:therapy; D001803:Blood Transfusion; D020520:Brain Infarction / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D002648:Child; D018450:Disease Progression; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D008297:Male; D010641:Phenotype; D015995:Prevalence; D012008:Recurrence; D012307:Risk Factors; D012737:Sex Factors